Matches in Wikidata for { <http://www.wikidata.org/entity/Q96603539> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q96603539 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96603539 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96603539 description "scientific article published on 18 June 2020" @default.
- Q96603539 description "wetenschappelijk artikel" @default.
- Q96603539 description "наукова стаття, опублікована 18 червня 2020" @default.
- Q96603539 name "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 name "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 type Item @default.
- Q96603539 label "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 label "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 prefLabel "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 prefLabel "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 P1433 Q96603539-AB35E6EE-096D-4561-B691-51F283AEC065 @default.
- Q96603539 P1476 Q96603539-63F0BAD0-4CD7-43CF-BCF8-A00B6345A2AF @default.
- Q96603539 P2093 Q96603539-1BF975FD-2966-4220-8D9E-72AD5CAA3758 @default.
- Q96603539 P2093 Q96603539-268ACF1F-75DA-4000-A7CA-EA23DB375F48 @default.
- Q96603539 P2093 Q96603539-68B7A1B9-5B86-4DB0-8A85-21B30D18F8C6 @default.
- Q96603539 P2093 Q96603539-70350931-C0F8-4AAE-9D59-FE320BB78CDE @default.
- Q96603539 P2093 Q96603539-9CE19B94-8E04-45ED-B1F0-BF8A862B5D76 @default.
- Q96603539 P2093 Q96603539-C5AAAB23-B847-44D0-9CCF-6536935C48DB @default.
- Q96603539 P2093 Q96603539-E68B1BA7-E367-461C-A225-771326B6352B @default.
- Q96603539 P31 Q96603539-3F5395A3-8F1C-4446-85AC-EAC2D45D4108 @default.
- Q96603539 P356 Q96603539-DE7C5BCA-C6EC-4B66-B583-4FA450F500DA @default.
- Q96603539 P577 Q96603539-944DB5D7-4F2F-4228-A6A9-DE7BD8EB6892 @default.
- Q96603539 P698 Q96603539-39007CB8-0B77-4389-8C9B-E61F76561751 @default.
- Q96603539 P921 Q96603539-FDB1EB4C-2DAA-450D-8FD4-11EDCFC8700F @default.
- Q96603539 P356 J.JAAD.2020.06.038 @default.
- Q96603539 P698 32565211 @default.
- Q96603539 P1433 Q15757046 @default.
- Q96603539 P1476 "Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: extension of the 2PRECISE study" @default.
- Q96603539 P2093 "Arthur David Burden" @default.
- Q96603539 P2093 "Christian Sieder" @default.
- Q96603539 P2093 "Hervé Bachelez" @default.
- Q96603539 P2093 "Michael Rissler" @default.
- Q96603539 P2093 "Piotr Jagiello" @default.
- Q96603539 P2093 "Roberto Orsenigo" @default.
- Q96603539 P2093 "Ulrich Mrowietz" @default.
- Q96603539 P31 Q13442814 @default.
- Q96603539 P356 "10.1016/J.JAAD.2020.06.038" @default.
- Q96603539 P577 "2020-06-18T00:00:00Z" @default.
- Q96603539 P698 "32565211" @default.
- Q96603539 P921 Q30314007 @default.